✦ LIBER ✦

Transfer factor: A potential agent for immunotherapy of cancer

✍ Scribed by C. Richard Meier; Albert F. LoBuglio

Publisher: Springer
Year: 1977
Tongue: English
Weight: 528 KB
Volume: 1
Category: Article
ISSN: 0364-2313
DOI: 10.1007/bf01556190

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

A review of transfer factor immunotherap

A review of transfer factor immunotherapy in cancer

✍ Albert F. Lobuglio; James A. Neidhart 📂 Article 📅 1974 🏛 John Wiley and Sons 🌐 English ⚖ 697 KB

Adjuvant immunotherapy of primary resect

Adjuvant immunotherapy of primary resected lung cancer with transfer factor

✍ Takehiko Fujisawa; Yutaka Yamaguchi; Hideki Kimura; Masaaki Arita; Masayuki Baba 📂 Article 📅 1984 🏛 John Wiley and Sons 🌐 English ⚖ 596 KB

One hundred seventy-one patients were studied in order to evaluate the clinical efficacy of the transfer factor (TF) for primary resected lung cancers under a randomized controlled trial. Eligible cases for evaluation were randomly chosen at 75 and 74 patients in TF and control groups, respectively.

Immunotherapy of viral infections with t

Immunotherapy of viral infections with transfer factor

✍ M. R. Mazaheri; Anne S. Hamblin; A. J. Zuckerman 📂 Article 📅 1977 🏛 John Wiley and Sons 🌐 English ⚖ 629 KB

## Abstract It has been reported that dialysable leucocyte extract preparations, thought to contain transfer factor, may be used therapeutically for the treatment of a variety of immunodeficiency syndromes. Clinical and laboratory studies have suggested that such preparations, in addition to transf

Potential of human γδ T lymphocytes for

Potential of human γδ T lymphocytes for immunotherapy of cancer

✍ Dieter Kabelitz; Daniela Wesch; Elke Pitters; Margot Zöller 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 French ⚖ 92 KB

## Abstract T lymphocytes are classified into 2 subsets based on their T‐cell receptor (TCR) expression. The vast majority of T cells expresses an αβ TCR heterodimer. These αβ T cells recognize antigenic peptides presented by MHC class I (for CD8^+^ T cells) or MHC class II molecules (for CD4^+^ T

Active specific immunotherapy potential

Active specific immunotherapy potential for the treatment of large bowel cancer

✍ Dr. Barry D. Kahan; Neal R. Pellis; Lynne P. Rutzky; Floyd Wiseman; Baldwin H. T 📂 Article 📅 1977 🏛 John Wiley and Sons 🌐 English ⚖ 588 KB

RNA-mediated transfer of tumor immunity

RNA-mediated transfer of tumor immunity —A new model for the immunotherapy of cancer

✍ Peter J. Deckers; Yosef H. Pilch 📂 Article 📅 1971 🏛 John Wiley and Sons 🌐 English ⚖ 841 KB

The adoptive transfer of tumor-specific transplantation immunity was accomplished in a syngeneic rat tumor-host system. Rats which received intravenous injections of spleen cells from Fisher 344/N rats immunized by amputation of growing isografts of a benz(a)pyrene-induced fibrosarcoma (BP-1R) manif